Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Protagonist Therapeutics (United States) | Researchclopedia

Back to institutions

Protagonist Therapeutics (United States)

Newarkcompany

166

Works

2,693

Citations

20

h-index

Top Research Topics

Hemoglobinopathies and Related Disorders Myeloproliferative Neoplasms: Diagnosis and Treatment Inflammatory Bowel Disease

Top Researchers

Jacqueline Bromberg University of Maryland, Baltimore

203 works46,601 citationsh-index: 63

Recent Research

Rusfertide rapidly decreases hematocrit in patients with suboptimally controlled polycythemia vera

Lee Ping Chew,Yelena Ginzburg,et al.

20250 citations

Microscopic Colitis

Iron Metabolism and Disorders

Monoclonal and Polyclonal Antibodies Research

Acute Myeloid Leukemia Research

Education Pedagogy and Practices

Immunotherapy and Immune Responses

Immunodeficiency and Autoimmune Disorders

Erythrocyte Function and Pathophysiology

Cancer Immunotherapy and Biomarkers

Richard H. Duerr

224 works36,392 citationsh-index: 68

Naval Daver The University of Texas MD Anderson Cancer Center

1,402 works33,434 citationsh-index: 89

Scott B. Snapper Université Mohammed VI Polytechnique

536 works32,705 citationsh-index: 85

Jason Gotlib Cancer Prevention Institute of California

693 works31,262 citationsh-index: 83

David Liu University of Louisville

580 works23,310 citationsh-index: 62

RESULTS FROM VERIFY, A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RUSFERTIDE FOR THE TREATMENT OF POLYCYTHEMIA VERA

Abdulraheem Yacoub,Andrew Kuykendall,et al.

20250 citations

Evaluation of Rusfertide, a Hepcidin Mimetic, on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled Crossover Thorough QT Study in Healthy Participants

Nishit B. Modi,Phillip Dinh,et al.

20250 citations

MPN-785: Results From VERIFY, an International, Randomized, Phase 3, Double-Blind, Placebo-Controlled Study of Rusfertide (First-in-Class Hepcidin Mimetic) for Treatment of Polycythemia Vera (PV)

Naveen Pemmaraju,Andrew Kuykendall,et al.

20250 citations

POSTER: MPN-785 Results From VERIFY, an International, Randomized, Phase 3, Double-Blind, Placebo-Controlled Study of Rusfertide (First-in-Class Hepcidin Mimetic) for Treatment of Polycythemia Vera (PV)

Naveen Pemmaraju,Andrew Kuykendall,et al.

20250 citations

An observational study of disease management in adult patients with polycythemia vera: results from a large U.S. claims database

Andrew Kuykendall,Lucy Bellamy,et al.

20250 citations